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Brucella is a Gram-negative facultative intracellular bacterium responsible for a chronic
disease known as brucellosis, the most widespread re-emerging zoonosis worldwide.
Establishment of a Th1-mediated immune response characterized by the production
of IL-12 and IFNγ is essential to control the disease. Leukotrienes derived from
arachidonic acid (AA) metabolism are known to negatively regulate a protective Th1
immune response against bacterial infections. Here, using genomics approaches we
demonstrate that Brucella abortus strongly stimulates the prostaglandin (PG) pathway
in dendritic cells (DC). We also show an induction of AA production by infected
cells. This correlates with the expression of Ptgs2, a gene encoding the downstream
cyclooxygenase-2 (COX-2) enzyme in infected DC. By comparing different infection
routes (oral, intradermal, intranasal and conjunctival), we identified the intradermal
inoculation route as the more potent in inducing Ptgs2 expression but also in inducing
a local inflammatory response in the draining cervical lymph nodes (CLN). NS-398, a
specific inhibitor of COX-2 enzymatic activity decreased B. melitensis burden in the
CLN after intradermal infection. This effect was accompanied by a decrease of Il10
and a concomitant increase of Ifng expression. Altogether, these results suggest that
Brucella has evolved to take advantage of the PG pathway in the harsh environment
of the CLN in order to persist and subvert immune responses. This work also
proposes that novel strategies to control brucellosis may include the use of COX-2
inhibitors.
Keywords: Brucella, COX-2, dendritic cells, intradermal infection, prostaglandins
Abbreviations: 5-LO, 5-Lipoxygenase; AA, Arachidonic Acid; BMDC, Bone marrow-derived dendritic cell; Ccl2, C-C-
chemokine ligand 2; Ccr7, C-C-chemokine receptor 7; CFU, Colony forming units; CLN, Cervical lymph nodes; COX-2,
Cyclooxygenase-2; DC, Dendritic cells; DMSO, Dimethyl sulfoxide; EP, Prostaglandin E receptor; Foxp3, Forkhead box 3;
GM-CSF, Granulocyte macrophage colony-stimulating factor; Gzmb, Granzyme B; IFN, Interferon; IL, Interleukin; LPS,
Lipopolysaccharide; moDC, Monocyte derived dendritic cell; MOI, Multiplicity of infection; NOS2, Nitric oxide synthase
2; NS-398, N-[2- (cyclohexyloxy)-4-nitrophenyl]-methanesulfonamide; PBMC, Peripheral blood mononuclear cells; PG,
Prostaglandins; PTGDS, Prostaglandin D synthase; PTGER, Prostaglandin E receptor; Ptgs2, Prostaglandin-endoperoxide
synthase 2; Th1, T helper 1; TLR, Toll-like receptor; TNF-α, Tumor Necrosis Factor α; TSA, Tryptic Soy Agar; TSB, Tryptic
Soy Broth.
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INTRODUCTION
Brucellosis is a disease caused by a Gram-negative facultative
intracellular bacterium belonging to the genus Brucella. It is the
most widespread re-emerging zoonosis worldwide affecting more
than half a million people each year (Seleem et al., 2010). Brucella
affects a wide range of land and aquatic mammals including
humans and livestock. Animals are Brucella primary hosts in
which the bacterium has a particular tropism for the reproductive
system, often leading to spontaneous abortion and sterility
responsible for severe economic losses (Pappas, 2010). Brucella
can be transmitted to humans in close contact with infected
animals mostly by ingestion of contaminated food or inhalation
of aerosolized contaminated particles (Moreno, 2014). The
Brucella species presenting the most important zoonotic potential
for humans are B. melitensis, B. abortus, B. suis, and B. canis
(Moreno, 2014). In human, the disease is characterized by an
acute phase, which mainly manifests itself by asthenia, recurrent
undulant fever and influenza-like symptoms. If the disease is not
cured, it can evolve into chronic brucellosis, which may result in
serious complications such as endocarditis or neurobrucellosis
(Franco et al., 2007; Dean et al., 2012). Currently, there is no
effective vaccine to prevent the disease in human highlighting the
importance to understand the physiopathology of the disease.
To establish a persistent infection, Brucella behaves as a
stealthy pathogen (Barquero-Calvo et al., 2007), using various
strategies to modulate the host immune response. For instance,
its unusual LPS plays a central role showing a low endotoxicity
and being poorly recognized by Toll-like-receptor 4 (TLR4)
(Lapaque et al., 2005; Lapaque et al., 2009; Conde-Álvarez et al.,
2012). Brucella can also modulate the protective Th1 immune
response characterized by the secretion of pro-inflammatory
cytokines such as IL-1β, IFNγ, TNF-α, or IL-12 (Zhan and
Cheers, 1995; Zhan et al., 1996; Martirosyan et al., 2011) by
inducing an early IL-10 secretion orchestrated by CD4+CD25+
T cells (Xavier et al., 2013).
It has also been shown that B. abortus can activate the 5-
LO responsible for the synthesis of leukotrienes derived from
AA (Fahel et al., 2015). The 5-LO activity impacts on pro-
inflammatory cytokine secretion including IL-12 and IFNγ
in vivo (Fahel et al., 2015). Thus, 5-LO seems to function as a
negative regulator of the protective Th1 response during mice
infection with B. abortus. However, AA can be metabolized by
different enzymes including the COX also known as Ptgs (Harizi
et al., 2008). COX enzymes are responsible for the rate-limiting
step in the biosynthesis of PG and other prostanoids among
them thromboxanes and prostacyclins (Figure 1). Three known
isoforms of COX have been identified so far: COX-1, COX-2 and
COX-3 whose physiological function is not yet fully elucidated
(Chandrasekharan et al., 2002; Chandrasekharan and Simmons,
2004). The constitutively and ubiquitously expressed COX-1
isoform is involved in basal and constitutive PG production.
On the contrary, COX-2 is expressed at very low levels and
is highly inducible following pro-inflammatory stimuli such as
cytokines or endotoxins. COX-2 converts AA into prostaglandin
H2 (PGH2), which is then converted into prostaglandin D2,
prostaglandin E2 (PGE2), prostacyclins, or thromboxane A2
depending on cell specific enzymes expression (Figure 1). The
context as well as the panel of PG receptors will define the pro- or
anti-inflammatory action of these lipid mediators. Thus, PG have
immunomodulatory traits that can worsen or improve bacterial
clearance. This dual activity is observed during Salmonella
Typhimurium infection in mice. Indeed, COX-2 inhibition
during the acute stage of the disease increases bacterial load
whereas at later stage it enhances mouse survival (Bowman and
Bost, 2004). A similar pattern is observed in mice infected with
Mycobacterium tuberculosis (Rangel Moreno et al., 2002).
Cyclooxygenase-2 has been shown to have different outcomes
during several bacterial and viral infections (Steer and Corbett,
2003; Agard et al., 2013) but little is known about its role
during Brucella infection. Some studies have reported the impact
of B. abortus and B. melitensis LPS on COX-2 expression in
monocytes (López-Urrutia et al., 2001). Both smooth-LPS (S-
LPS) were found to induce COX-2 expression in THP-1 cell line
and rat-peritoneal macrophages in a dose-dependent manner.
PGE2 synthesis and its impact in bovine PBMC infected with
live and γ-irradiated B. abortus have also been assessed showing
that IL-2 and IFNγ suppression was independent on COX-1 and
COX-2 (Stevens and Olsen, 1994) but these in vitro studies were
not confirmed in vivo.
The aim of our study is to determine whether COX-2 is
involved in protection against Brucella infection or exacerbation
of the Brucella burden. We have investigated the ability of
B. abortus to stimulate the AA-COX-2 pathway in infected
human moDC and in mouse GM-CSF BMDC and studied the
impact of COX-2 inhibition in vivo after intradermal infection
with B. melitensis. Here, we demonstrate that B. abortus enhances
AA production in human moDC and Ptgs2 expression both in
human moDC and murine GM-CSF BMDC. The comparison of
different inoculation routes allowed us to identify the intradermal
route as the more potent to induce Ptgs2 expression and local
inflammatory response in CLN. COX-2 inhibition decreases the
bacterial burden in CLN characterized by a decrease of Il10
and an increase of Ifng expression. Thus, further development
of COX-2 inhibitors may represent a novel therapeutic strategy
against Brucella.
MATERIALS AND METHODS
Ethics Statement
This study was carried out in strict accordance with the
guidelines of the Council of the European Union (Directive
86/609/EEC) regarding the protection of animals used for
experimental and other scientific purposes. The experimental
protocol was approved by the institutional animal care and
use committee of the Aix-Marseille University (N◦ 87–848,
October 19, 1987, Paris, modified by Decree 2001-464 and
Decree 2001-131 relative to European Convention, EEC directive
86/609). All experiments were done in accordance with
French and European guidelines for animal care. Blood was
obtained from the Etablissement Français du Sang. As it is a
commercial product, the Ethics Committee agreement is not
required.
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FIGURE 1 | The PGs biosynthetic pathway. In response to different types of stimuli (hormones or cytokines), phospholipase A2 is activated to produce AA from
membrane phospholipids. Free AA can be metabolized by the COX-2 enzyme to produce PGs H2 (PGH2). PGH2 is then converted into prostanoids through the
action of various synthases differentially expressed in cells. PG, Prostaglandins; TX, Thromboxane; NSAIDs, Nonsteroidal anti-inflammatory drugs; COX-2,
Cyclooxygenase-2; iPGES, inducible Prostaglandin synthase; TxA2, Thromboxane A2; PGF2α, Prostaglandin F2α; PGI2, Prostaglandin I2; PGE2, Prostaglandin E2.
Mice and Bacteria
Six to eight weeks old females C57BL/6 (Charles River
Laboratories) were maintained under pathogen-free conditions
and fed sterile food and water ad libitum. All infections were
performed under Animal Biosafety Level 3 facility.
Bacterial Strains
Orentia tsutsugamushi strain Kato (CSUR R163) (gift from Dr.
Jean-Louis Mège, URMITE, Marseille, France) was propagated
in L929 cells (ATCC), as previously described (Barry et al.,
2012). Briefly, highly infected cells were sonicated, or lysed
using glass beads for O. tsutsugamushi, and centrifuged at
500 × g for 10 min to remove cell debris. Supernatants were
collected and centrifuged at 10,000 × g for 10 min to pellet
the bacteria. Live bacteria were quantified using infected cell-
counting units. Coxiella burnetii organisms (RSA493 Nile Mile
strain) (gift from Dr. Jean-Louis Mège, URMITE, Marseille,
France) were obtained by passage in BALB/c mice (Charles
River Laboratories) and culture in L929 cells. The concentration
of organisms was determined by immunofluorescence using
specific antibodies and/or PCR using known concentrations of
bacterial DNA. The quantification of organisms was performed
as previously described (Barry et al., 2012). Bacterial viability
was assessed using the LIVE/DEAD Bac Light bacterial viability
kit (Invitrogen). Brucella abortus strain 2308 and Brucella
melitensis strain 16M (gift from Dr Ignacio Moriyon, University
of Pamplona, Spain) were grown on TSA (Sigma-Aldrich)
at 37◦C for 7 days, as previously described (Pizarro-Cerdá
et al., 1998). The Twist-Marseille (CNCM I-2202) strain of
Tropheryma whipplei (gift from Dr. Jean-Louis Mège, URMITE,
Marseille, France), a bacterium known to live in macrophages,
was cultured in HEL cells and purified. Quantification of inocula
was performed by measuring the percentage of infected cells
by immunofluorescence, as previously described (Gorvel et al.,
2010).
Isolation of Human moDC
Peripheral blood mononuclear cells from buffy coats were
recovered from the Ficoll-Hypaque (GE healthcare) interface
after centrifugation at 700 × g for 20 min. Monocytes
and T lymphocytes were isolated from PBMCs using
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magnetic beads coupled to antibodies specific for CD14
and CD3, respectively, as described by the manufacturer
(Miltenyi Biotec). The purity of the monocyte and T-cell
preparations was assessed by flow cytometry and was greater
than 98%. Monocytes were then incubated in RPMI 1640
(Gibco) containing 20 mM HEPES, 2 mM glutamine,
10% fetal calf serum (FCS) (Invitrogen), 0.1 ng/mL IL-4
and 1 ng/mL granulocyte-macrophage colony-stimulating
factor (GM-CSF) (R&D Systems) for 7 days to obtain
moDC.
In vitro Generation of BMDC
Bone marrow-derived dendritic cells were prepared from 6
to 8 week-old females C57BL/6 mice as previously described
(Salcedo et al., 2008). Briefly, tibias and femurs were flushed
with RPMI-5%FCS (Eurobio)-50 µM 2β-mercaptoethanol
(Sigma−Aldrich) to extract bone marrow.
In order to generate GM-CSF-BMDC, 3.106 cells per well
were seeded onto 6-well plates in medium supplemented with
supernatant of J558L GM-CSF producing cell line (gift from
Dr. Philippe Pierre, Centre d’Immunologie de Marseille-Luminy,
Marseille, France). The medium was changed at day 2.5.
In vitro Infection Assays
GM-CSF-DC were infected with B. abortus smooth virulent
strain 2308 using a MOI of 30:1. Bacteria were centrifuged
onto cells at 400 × g for 10 min at 4◦C. Then, cells were
incubated for 30 min at 37◦C with 5% CO2. After two washes
with medium, cells were incubated for one hour with medium
containing antibiotic [gentamicin (Sigma−Aldrich) at 50 µg/ml]
in order to kill the extracellular bacteria. Thereafter, the antibiotic
concentration was decreased at 10 µg/ml until the end of the
infection time.
In Vivo Bacterial Challenge
Brucella melitensis 16M with a chromosomal integration of
DsRed was used in this study. B. melitensis were grown
under shaking in TSB (Sigma−Aldrich) containing 25 µg/ml
kanamycin (Sigma−Aldrich) at 200 rpm for 16 h at 37◦C. Inocula
were prepared by pelleting bacteria and by adjusting bacterial
concentration in endotoxin free PBS (Gibco) to obtain the right
concentration depending on the inoculation route. Oral infection
was performed as previously described (von Bargen et al., 2014).
Briefly, pelleted bacteria were re-suspended to previously heat-
sterilized 5% milk and adjusted at respective MOI in 5% milk
(Scharlau). For all the other inoculation routes, mice were
anesthetized with Ketamine/Xylazine (Virbac). For intranasal
infection, the bacterial inoculum containing 105 CFU suspended
in 35 µL of endotoxin free PBS (Gibco) was applied onto
mice nostril via pipet. For intradermal infection, the bacterial
inoculum containing 104 CFU suspended in 10 µL of endotoxin
free PBS was injected into the ear pinna. For conjunctival
infection, the bacterial inoculum containing 109 CFU suspended
in 10 µL was applied onto conjunctival surfaces (5 µL per
eye). In some experiments, the selective COX-2 inhibitor NS-
398 (Cayman Chemicals) were administered by intraperitoneal
injection (15 mg/kg) right after intradermal infection. A stock
solution of NS-398 was prepared in DMSO (Sigma−Aldrich)
and was diluted in PBS just prior to treatment to the right
concentration in a 1:3 (DMSO:PBS) ratio for a total volume of
100 µL per mouse or vehicle control (DMSO:PBS alone).
Treatments were repeated daily for 7 days. At 8 and 29 days
post-infection mice were sacrificed by cervical dislocation.
Immediately after sacrifice, CLN (including mandibular,
accessory mandibular, and superficial parotid lymph nodes
referred here as CLN; Van den Broeck et al., 2006) and spleens
were collected, weighted, and proceeded for bacterial count and
RNA extraction.
Analysis of Organ Bacterial Burden
Spleens and CLN were removed and homogenized in Triton
X-100 (Sigma−Aldrich) 0.1%. Serial dilutions were performed
in PBS, and plated in triplicate onto TSA agar. CFU were
enumerated after 3−4 days of culturing at 37◦C.
Microarrays
Monocyte derived dendritic cells (5.106 cells per well) were plated
in 6-well plates and stimulated or not with B. abortus (MOI
of 300:1) for 6 hours, and total RNA was then extracted using
the RNeasy minikit (Qiagen) and DNase treatment. This study
utilized the 4X44k Human Whole Genome microarrays (Agilent
Technologies), representing 44,000 probes. Reverse transcription,
samples labeling, and hybridization were performed according
to the protocols specified by the manufacturer (One-Color
Microarray-Based Gene Expression Analysis). Three samples
per experimental condition were included in the analysis. The
slides were scanned at a 2-mm resolution with a G2505C DNA
microarray scanner (Agilent Technologies).
RNA Extraction, RT, and q-PCR
Total RNAs from infected GM-CSF-BMDC were extracted
using RNeasy Micro Kit (Qiagen) following manufacturer’s
instructions. CLN were stabilized in RNAlater (Qiagen)
immediately after sampling. Organs were homogenized in
RLT buffer (Qiagen) and then extracted using RNeasy Micro
Kit (Qiagen) following manufacturer’s instructions. cDNAs
were obtained by using Quantitech Reverse Transcription Kit
(Qiagen) following manufacturer’s instructions using 300 ng
of RNA as a matrix. qPCR were conducted using a 7500
Fast-Real-time PCR (Applied Biosystem) with SYBER Green
(Takara) following manufacturer’s instructions. HPRT was
used as housekeeping gene to determine 1Ct. Fold change
compared to base line expression in uninfected cells, or
control mice was determined using 2−11Ct method where
11Ct = (Cttarget−CtHPRT)infected−(Cttarget−CtHPRT)non−infected
as previously described (Papadopoulos et al., 2016). mRNAs
whose expression level was twice as high compared to control
were considered as significantly up-regulated. Primers used in
this study are listed in Table 1.
Arachidonic Acid Quantification
Monocyte derived dendritic cells were stimulated by bacterial
pathogens (MOI 50:1 for T. whipplei or 20:1 for others) or
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TABLE 1 | Primers used for analysis of gene expression upon infection.
Genes Forward Primers Reverse Primers
HPRT AGCCCTCTGTGTGCTCAAGG CTGATAAAATCTACAGTCATAGGAATGGA
Ifng TCAAGTGGCATAGATGTGGAAGAA TGGCTCTGCAGGATTTTCATG
Il6 GAGGATACCACTCCCAACAGACC AAGTGCATCATCGTTGTTCATACA
Gzmb ATCAAGGATCAGCAGCCTGA CATGATGTCATTGGAGAATGTCT
Nos2 CAGCTGGGCTGTACAAACCTT CATTGGAAGTGAAGCGTTTCG
Ptgs2 (Cox2) ACCTCTGCGATGCTCTTCC TCATACATTCCCCACGGTTT
Ccl2 GCCTGCTGTTCACAGTTGC ATTGGGATCATCTTGCTGGT
Ccr7 GTGGTGGCTCTCCTTGTCAT GAAGCACACCGACTCGTACA
Il10 GGTTGCCAAGCCTTATCGGA ACCTGCTCCACTGCCTTGCT
Foxp3 AGGAGCCGCAAGCTAAAAGC TGCCTTCGTGCCCACTGT
Tnf CATCTTCTCAAAATTCGAGTGACAA TGGGAGTAGACAAGGTACAACCC
Il4 ACTCTTTCGGGCTTTTCGAT TTGCATGATGCTCTTTAGGC
Escherichia coli LPS (Sigma−Aldrich) (1 µg/ml) for 16 h,
suspended in 0.3 mL of cold methanol (MeOH). Fatty acid
methyl esters (FAME) extraction was performed as previously
described (Schutter and Dick, 2000; Ecker et al., 2012), 15 µL of
MeOH/Deuterium-labeled eicosanoids (LTB4-d4 and 5-HETE-
d8, 400 ng/ml) standard solution were added to 0.2 ml of
homogenate. After centrifugation, supernatants were diluted
in 10 mL of hydrochloric acid (HCl) 0.02 M and submitted
to solid-phase extraction on C18 cartridge (Macherey Nagel).
After complete loading, columns were washed, dried and lipid
mediators were eluted in methyl formate (MeFor). Solvent was
evaporated under N2 and samples were dissolved within 30 µL
MeOH and stored at−80◦C.
For AA quantification, 0.1 ml of homogenates were extracted
in dichloromethane/methanol/water, in the presence of 2 µg
glyceryl triheptadecanoate (Sigma−Aldrich) and hydrolyzed in
potassium hydroxyde (KOH) (0.5 M in MeOH) at 50◦C for
30 min. Lipids were transmethylated in 14% boron trifluoride
MeOH solution (Sigma−Aldrich) and hexane at 80◦C for 1 h.
FAME were extracted with hexane, dried and dissolved in ethyl
acetate.
Fatty acid methyl esters were analyzed by gas−liquid
chromatography as previously described (Lepage and Roy, 1986)
on a Clarus 600 Perkin Elmer system using Famewax RESTEK
fused silica capillary columns (30 m × 0.32 mm i.d, 0.25 µm
film thickness). Oven temperature was programmed from 110◦C
to 220◦C at a rate of 2◦C per min and the carrier gas was
hydrogen (0.5 bar). The injector and the detector were at 225◦C
and 245◦C, respectively. LC-MS/MS analysis was performed on
UHPLC system (Agilent LC1290 Infinity) coupled to Agilent
6460 triple quadrupole MS (Agilent Technologies) equipped with
electrospray ionization source. Separation was done at 40◦C on
a Zorbax SB-C18 column (2.1 mm, 50 mm, 1.8 µm) (Agilent
Technologies). The mobile phases were, respectively water, ACN
and FA (75/25/0.1) (A) and ACN, FA (100/0.1) (B). The linear
gradient was as follows: 0% B at 0 min, 85% B at 8.5 min, 100%
B at 9.5 min, 100% B at 10.5 min, and 0% B at 12 min. The
flow rate was 0.35 mL/min. The autosampler was set at 5◦C
and the injection volume was 5 µL. Electrospray ionization was
performed in negative ion mode with a spray voltage fixed at
−3500 V. After optimization, source conditions were as follows:
source temperature was 325◦C, nebulizer gas (nitrogen) flow rate
was 10 L/min, sheath gas temperature was 400◦C and sheath
gas (nitrogen) flow rate was 12 L/min. Analyses were acquired
in multiple reaction mode (MRM) using nitrogen as collision
gas. For each compound the conditions of separation: retention
time in minute (RT), and of quantification were defined: specific
Q1/Q3 transition (T) fragmentor (F), and collision energy (CE).
Thus, optimized parameters were as follows: LTB4 (RT: 4.32 min,
T: 335/195, F: 115 V; CE: 4 V), LTB4-d4 (RT: 4.31 min, T: 339/197,
F: 120 V, CE: 6 V). Peak detection, integration and quantitative
analysis were performed using Mass Hunter Quantitative analysis
software (Agilent Technologies).
Statistical Analysis
The results are expressed as mean ± SD and statistical
significance was assessed using the unpaired, two-tailed Student’s
t-test or by analysis of variance (ANOVA) followed by
Tukey’s multiple comparison test provided by GraphPad Prism
software when more than two conditions were analyzed
simultaneously. p values over 0.05 were not considered as
significant.
RESULTS
B. abortus Infection of moDC and
GMCSF-BMDC Stimulates
AA-Cyclooxygenase Pathway
We first measured the AA concentration in B. abortus
infected moDC culture supernatants at 16 h post-infection.
In parallel, other intracellular bacteria (T. whipplei,
C. burnetii, O. tsutsugamushi) were tested. Only B. abortus
and O. tsutsugamushi induced a significant AA production
compared to non-stimulated moDC (Figure 2A).
AA can be metabolized by the COX pathway (Harizi et al.,
2008). Thus, to determine the impact of B. abortus on this
pathway, we analyzed the transcriptional profile of several
key genes involved in the PG and leukotriene pathways
in infected cells (Figure 2B). Compared to unstimulated
cells, infected human moDC strongly expressed PTGS2
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FIGURE 2 | Prostaglandins pathway highlights induced AA metabolism in human moDC and mice GM-CSF BMDC upon Brucella abortus infection.
(A) moDC were stimulated or not (NS) during 16 h with Tropheryma whipplei (30:1), B. abortus (20:1), Coxiella burnetii (20:1), Orentia tsutsugamushi (20:1), or
Escherichia coli LPS (1 µg/mL) and then treated for AA dosage. The AA concentration after infection was compared to unstimulated condition using unpaired,
two-tail Student’s t-test (∗p < 0.05) (Results of three independent experiments). Results are given as mean ± SD. (B) Transcriptomic analysis. moDC were
stimulated or not with B. abortus, for 6 h. RNA was extracted, and a microarray was performed. Statistical analysis was performed using unpaired, two-tail Student’s
t-test (∗p < 0.05; ∗∗p < 0.005; ∗∗∗p < 0.001) and results are given as mean ± SD (Results of three independent experiments). (C) GMCSF BMDC from C57BL/6
mice were infected with B. abortus 2308 (30:1). At 4, 8, 24, and 48 h post-infection, cells were recovered and RNA was extracted. Gene expression is represented
as a fold increases between non-infected and infected cells. Statistical analyses were performed by using the comparative CT Method (11CT method) given by
2−11CT. The dotted line represents a fold increase of 2, the statistical significant threshold in this method. Results are given as mean ± SD (Results of three
independent experiments).
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(33 times higher) and in a lesser extend PTGER2, PTGER4
and PTGDS (1,7, 3,1, and 1,3 times higher, respectively)
(Figure 2B, upper panel). On the contrary, none of the
genes involved in the leukotriene pathway were up-
regulated following Brucella infection (Figure 2B, lower
panel).
We next investigated the expression of Ptgs2 in murine GM-
CSF-derived DC at 4, 8, 24, and 48 h post-infection. We observed
that as in human DC, murine Ptsg2 mRNA level was strongly up
regulated. Ptsg2 expression was time-dependent, reaching a peak
at 24 h post-infection (229.4-fold up regulated compared to non-
infected cells) (Figure 2C).
These results show that B. abortus infection is capable of
stimulating the AA metabolic pathway and downstream PG
pathway both in human and mice DC.
Intradermal Infection Is Characterized by
a Strong Ifng and Ptgs2 Signature
We next investigated the involvement of the PTGS-2 pathway
in vivo upon infection in mice. We have first compared three
different Brucella strains (B. abortus 2308, B. melitensis 16M, and
B. suis 1330) and their ability to colonize CLN at 8 and 15 days
post-infection using the oral infection model we previously
shown to induce a specific colonization of CLN (von Bargen
et al., 2014). We avoided to use intraperitoneal inoculation since
it is associated to systemic infection and recedes from Brucella
physiological routes of infection or vaccination (Grilló et al.,
2012). Although bacterial loads in CLN were very similar at
any time point for all Brucella species (Supplementary Figure
1A), B. melitensis and B. suis induced a higher lymphadenopathy
compared to B. abortus at 15 days post-infection suggesting an
enhanced inflammatory response in the CLN (Supplementary
Figure 1B). We then decided to continue this study with
B. melitensis 16M.
WT C57BL/6 mice were inoculated with B. melitensis by
oral administration (with 109 bacteria per mouse) as previously
described (von Bargen et al., 2014) or by intranasal (with 105
bacteria per mice), conjunctival (109 bacteria per mice) or
intradermal (104 bacteria per mice) routes. Mice were sacrificed
at 8 and 29 days post-infection and the weight and bacterial load
of CLN and spleens were measured (Figures 3A,B).
At 8 days post-infection, the intradermal route was the only
route capable of inducing lymphadenopathy compared to mock-
treated mice and to other inoculation methods (Figure 3A, Left
panel). No splenomegaly was observed at 8 days post-infection
compared to mock-treated mice (Figure 3A, Right Panel).
These results correlated with bacterial loads. CFU numbers in
CLN were higher in mice infected intradermally compared to
the other infection routes (Figure 3B, Left panel). However,
spleens were poorly colonized as observed in all infection
conditions (Figure 3B, Right panel). At 29 days post-infection,
all inoculation routes resulted in lymphadenopathy and induced
splenomegaly (Figure 3A). The increase in CLN and spleen
weight was not associated with an increase in bacterial load
(Figure 3B). This suggests the establishment of an inflammatory
response in these organs.
We next investigated the local immune response induced
by Brucella infection in the spleens and CLN by extracting
mRNA at 8 and 29 days post-infection. Results were analyzed
as a fold increase compared to their mock counterparts. No
significant response was observed in the spleen for any infection
routes (Supplementary Figure 2). On the contrary, a clear
inflammatory response was observed in the CLN of mice infected
intradermally from 8 days post-infection onwards (Figure 3C).
This response led to a strong up-regulation of Ifng, Gzmb and
Ptgs2 mRNAs (64, 18.6, and 30.8-fold, respectively) (Figure 3C).
At 29 days post-infection, Ifng, Gzmb, and Il6 mRNA levels
strongly decreased whereas a strong up-regulation of Ptgs2 and in
a lesser extent Nos2 and Ccl2 mRNA levels remained (Figure 3C).
The inflammatory response was less pronounced using the other
inoculation routes. Indeed, no significant changes between day
8 and 29 were observed in terms of mRNA expression levels
except for conjunctival inoculation displaying an increase of Nos2
and Ccl2 mRNA levels (Fold change: 10.3 and 2.9, respectively)
(Figure 3C).
In conclusion, the intradermal infection route is the most
potent at inducing inflammatory genes expression and Ptgs2
seems to be a robust marker of Brucella intradermal infection
compared to intranasal, conjunctival or oral infection routes.
At 29 days post-infection following B. melitensis intradermal
inoculation, the expression of Il6 was significantly higher
compared to intranasal infection. Nos2 (compared to the
oral and intranasal routes), Ptgs2 and Ccl2 genes (compared
to all the other routes) were also increased (Figure 3C).
Interestingly, no systemic response was observed in mice
sera at any time independently from the inoculation route
except for IFN-γ after intradermal infection. However, low but
significant amounts of TNF-α were detected in the sera of mice
infected intradermally at 8 days post-infection (Supplementary
Figure 3).
Overall, these results strongly suggest that in the CLN
after intradermal infection a robust inflammatory response
characterized by an Ifng and a Ptgs2 signature takes place.
COX-2 Inhibition Reduces Bacterial
Burden In vivo
After having identified that the intradermal route was the
more potent to induce Ptgs2 expression during B. melitensis
infection, we evaluated in vivo the involvement of COX-2 during
infection. WT C57BL/6 mice were challenged intradermally with
B. melitensis (104 bacteria per mice) and were given NS-398, a
specific COX-2 inhibitor, or DMSO vehicle (mock control) by
intraperitoneal administration daily for 7 days.
We first looked at CLN and spleen weights at 8 days
post-infection. Independently of the treatment, infected mice
presented a lymphadenopathy compared to uninfected mice.
However, NS-398 treatment induced a decrease in CLN weight
compared to non-treated infected mice (Figure 4A, Left panel).
This effect was consistent with the anti-inflammatory properties
of NS-398. No significant effect could be observed in the spleen
(Figure 4A, Right panel). This response was accompanied by a
decrease of CFU numbers in CLN in treated mice (Figure 4A,
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FIGURE 3 | The intradermal inoculation pathway induces a strong local inflammatory response in CLN. C57BL/6 mice (n = 5 per group) were infected
using the routes of infection described in the methods section. At 8 and 29 days post-infection, mice were sacrificed and organs were weighed and analyzed for
their bacterial loads by plating homogenates on nutrient agar. Data represent mean of CLN (Left panel) and spleen (Right panel) weight (A) or CFU per organ (B) from
three independent experiments. Analysis significance was determined using ANOVA (∗p < 0.05; ∗∗p < 0.005; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001). (C) C57BL/6 mice
(n = 5 per group) were infected using different routes of infection as described in methods section. At 8 and 29 days post-infection, total RNA of the CLN was
extracted and analyzed for inflammatory response gene expression by reverse transcription real-time PCR. Results are given as fold increase compared to the signal
obtained for mock-infected mice. Statistical significance was determined using unpaired, two-tailed Student’s t-test (Results of three independent experiments)
(∗p < 0.05; ∗∗p < 0.005; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001) and &significant compared to the oral route; #significant compared to the intranasal route and ‡significant
compared to the conjunctival route using ANOVA.
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FIGURE 4 | Cyclooxygenase-2 inhibition induces a decrease of bacterial burden in draining lymph nodes. C57BL/6 mice (n = 5) were infected with
B. melitensis (104 bacteria per mice) intradermally into ear pinnae. After infection mice received 15 mg/kg of COX-2 inhibitor (NS-398) or DMSO (mock-treated mice)
intraperitoneally daily for 7 days. Data represent two independent experiments. (A) At 8 days post-infection mice were sacrificed and organs were harvested and
CLN (Left panel) and spleen (Right panel) were weighted. Statistical significance was determined using ANOVA (∗p < 0.05; ∗∗∗∗p < 0.0001). (B) At 8 days
post-infection mice were sacrificed and organs were harvested and analyzed for their CLN (Left panel) or spleen (Right panel) bacterial loads by plating homogenates
on nutrient agar. Statistical significance was determined using unpaired, two-tailed Student’s t-test (∗∗p < 0.005). (C) At 8 days post-infection, total RNA of the CLN
was extracted and analyzed for expression of genes involved in inflammatory response by reverse transcription real-time PCR. Results are given as fold increase
compared to the signal obtained for mock-infected mice. Statistical significance was determined using unpaired, two-tailed Student’s t-test (∗∗p < 0.005;
∗∗∗p < 0.001; ∗∗∗∗p < 0.0001).
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Left panel) and no significant response was observed in the spleen
(Figure 4B, Right Panel).
The local inflammatory response in NS-398-treated mice was
characterized by a strong decrease of Il10 and Nos2 expression
and in a lesser extent of Ccr7 and Foxp3 compared to untreated
mice. However, Ifng mRNA level strongly increased following
NS-398 treatment. All the other genes tested did not exhibit any
significant changes in their expression (Figure 4C).
Altogether, these results indicate that inhibition of COX-
2 decreases bacterial load in CLN by acting on Il10 and Ifng
expression levels.
DISCUSSION
In this study, we investigated the impact of Brucella spp. infection
on the COX-2 metabolic pathway. We first assessed the ability of
B. abortus to stimulate AA production in DC. We also confirmed
using a genomic approach that PG pathway downstream partners
were overexpressed. We observed that B. abortus triggers a higher
level of AA in human moDC infected with B. abortus compared
to cells infected with other intracellular bacteria (C. burnetii, T.
whipplei, O. tsutsugamushi). This response was accompanied by
an increase of Ptgs2 mRNA levels in both human and murine
DC. Interestingly, we did not detect any major change in the
expression profile of the leukotriene pathway and specifically for
ALOX5, the gene encoding for the 5-LO in humans. This result
is contradictory with previously published data showing that 5-
LO was strongly up-regulated in Brucella infected spleens as early
as one-week post-infection in mice and was accompanied by
leukotriene B4 and lipoxin A4 production (Fahel et al., 2015).
This discrepancy may be explained by the in vitro DC model
used in our study compared to total splenocytes used in the
study published in 2015 and also possible differences between the
mouse and human models. Moreover, cells expressing 5-LO have
not yet been identified in vivo, thus, it could be possible that DC
are not the source of leukotrienes during B. abortus infection.
Transcriptional profiling showed an increase of PTGER2,
PTGER4, and PTGSD expression in infected human moDC
compared to unstimulated cells. Interestingly, it has been
reported that PGE2 can stimulate IL-10 secretion by mature
BMDC leading to a decrease of IL-12 secretion. This effect is
dependent on the expression of EP2/EP4 receptors encoded by
Ptger2 and Ptger4, respectively (Harizi et al., 2003). Similarly,
macrophage treatments with PG analogs stimulating the EP2/EP4
receptors lead to an increase of IL-10 secretion and concomitantly
a decrease of TNF-α secretion (Shinomiya et al., 2001). Moreover,
in a Pseudomonas aeruginosa intranasal infection model, this
immunomodulatory effect towards IL-10 secretion seems to be
mediated by EP2 since EP2−/− mice presented a lower bacterial
burden in the lung (Sadikot et al., 2007). Considering the negative
impact of IL-10 on the establishment of a protective immune
response during brucellosis, PG pathway could contribute to
bacterial persistence.
Then, we determined the levels of expression of Ptgs2 in vivo
using different infection routes. For this purpose, we chose
to study physiologically relevant inoculation routes such as
nasal, oral, and conjunctival infection routes that mimic natural
exposure to bacteria. We also included the intradermal infection
route often used for vaccination (Kim et al., 2012). We focused
on CLN since CLN also drains the eye (Hamrah and Dana, 2007)
and the nasal mucosa (Wolvers et al., 1999) and we previously
shown that this organ was preferentially targeted by Brucella
after oral inoculation (von Bargen et al., 2014). COX-2 being
important during inflammatory process, contrary to the in vitro
experiments, we decided to use B. melitensis as it seems that this
species induced an enhanced inflammation in CLN compared to
B. abortus.
As anticipated, we observed a tropism of bacteria for the CLN
and a marked lymphadenopathy compared to mock-treated mice
as soon as 8 days post-infection in mice infected intradermally
and in all conditions at 29 days post-infection. This effect was
particularly marked when using the intradermal route. When
looking at the local immune response in CLN, we observed
that the intradermal route induced a particular gene signature
characterized by a strong up-regulation of Ifng and Ptgs2 mRNA
levels compared to the other tested routes. However, we cannot
exclude a difference in terms of kinetics due to the fact that
intradermal infection delivers directly the bacteria into the tissue.
On the contrary, oral, intranasal, and conjunctival inoculations
expose bacteria to physiological barriers such as mucosal surfaces
that can delay the bacterial trafficking to the draining lymph
nodes. Indeed, we observed that at 8 days post-infection bacterial
load was significantly higher after intradermal infection but this
difference tends to be reduced at later time points. Moreover,
using a Yersinia pestis intradermal infection model it has been
shown that bacterial dissemination does not involve bacteria
active transport through phagocytes to the draining lymph nodes
(Gonzalez et al., 2015). At the beginning of the chronic phase
(29 days post-infection), we observed a strong decrease of Ifng,
Il6, Gzmb concomitant with and an increase of Nos2, Ptgs2
mRNA levels. Interestingly, it has recently been shown that
synergic induction of COX-2 by IFN-γ and TNF-α limits type-
1 immune response in tumor microenvironment by concomitant
action of IL-10, NOS2, and Indoleamine 2,3-dioxygenase (Wong
et al., 2016). Thus, we can hypothesize that the induction of Ptgs2
is beneficial for the bacteria.
We then used a specific COX-2 inhibitor (NS-398) and
demonstrated the beneficial potential of such an inhibition in
favor of the host. Indeed, COX-2 inhibition correlated with a
decrease in bacterial load in CLN concomitant with a decrease
of Ccr7, Il10, Foxp3, Nos2 mRNA levels and an increase of
Ifng expression. At early time points, the induction of Ptgs2
gene expression could be used by the bacteria to stimulate not
only their replication but also the migration of the infected
cells to other secondary organs as suggested by the effect on
Ccr7 expression. It is also known that Th1 immune response
characterized by IFN-γ and IL-12 secretion is important to
control infection and that production of IL-10 has a negative
impact in the course of brucellosis control by the host (Zhan and
Cheers, 1995; Brandao et al., 2012). Then, we can hypothesize
that the beneficial effect observed in the presence of COX-2
inhibitor treatment can be associated with a strong Th1 response.
Moreover, it has been demonstrated that in absence of IL-10,
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mice are more resistant to Brucella infection and this effect
is correlated with an increase of pro-inflammatory cytokine
secretion (Corsetti et al., 2013). The decrease of Il10 mRNA
levels is also accompanied by a decrease of Foxp3 expression, a
marker of regulatory T lymphocytes (T-reg). After intraperitoneal
infection, it has been shown that CD4+CD25+ T cells produce
IL-10 during acute brucellosis that favor bacterial persistence
in mice (Xavier et al., 2013). CD4+CD25+ T cell population
in parotid and retropharyngeal lymph nodes has been shown
to increase following conjunctival infection in sheep (Suraud
et al., 2007). CD4+CD25+ T cells with regulatory activity express
the transcription factor Foxp3 (Hori et al., 2003). Interestingly,
following NS-398 treatment, we observed a significant decrease
of Foxp3 expression. This finding is in accordance with the
decrease of Il10 expression. Thus, we hypothesize that infection
stimulates regulatory/suppressor T-cells that can favor bacterial
persistence through the secretion of IL-10. A similar effect
has been described during Mycobacterium tuberculosis infection
where COX-2/PGE2 axis stimulates T-reg expansion (Garg et al.,
2008; Holla et al., 2016). Thereby, T-reg accumulation contributes
to the decrease of bacterial clearance in infected mice (Kursar
et al., 2007). During Francisella tularensis live vaccine strain
intranasal infection, the inhibition of the COX-1 and COX-2
increased the number of IFN-γ producing T lymphocytes in the
lung leading to a decrease of the bacterial load (Woolard et al.,
2008). This is correlated with our observations showing that
COX-2 inhibition leads to an increase of Ifng mRNA levels in
CLN.
Our results corroborate other studies which have investigated
the involvement of the COX-2 pathway during bacterial infection
by Pseudomonas aeruginosa (Sadikot et al., 2007), Burkholderia
pseudomallei (Asakrah et al., 2013), and Streptococcus
pyogenes (Goldmann et al., 2010). COX-2 inhibition translates
into a decrease of bacterial burden in CLN. It would be
interesting to look at later time points to know whether
or not COX-2 inhibition can cause a bacterial clearance.
Taken together, our results suggest that Brucella has taken
advantage of the PG pathway to survive and replicate in
host cells and that COX-2 inhibition is not only crucial
to control brucellosis but also other bacterial infectious
diseases.
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